Higgins John L reported tax withholding involving 5,562 shares of BIO-TECHNE Corp at $72.51 for −$403k on Sep 28, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
Director
DIR
Filed Sep 30, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$403,300.62Shares × reported price
Shares traded
5,562Common Stock
Price per share
$72.51Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
77,254Direct
Trade date
Sep 28, 2026Tax withholding
Filed
Sep 30, 2026, 4:13 PM ET2-day reporting delay
Accession
0000914190-26-000142Code F · Transaction 231663
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 28, 2026Option exercise15,940$0.00$0Trade 231664
Sep 28, 2026Option exercise15,940$0.00$0Trade 231662
3 transaction rows in this filing. Joint filers share the same rows.

TECH price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TECH · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −0.2%1w ago 0%1d ago +0.2%
Returns since7d +0.1%30d +0.3%90d180d1y

Footnotes in full

F1: The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.